» Articles » PMID: 12781001

Human Metapneumovirus Infections in Hospitalized Children

Overview
Date 2003 Jun 5
PMID 12781001
Citations 190
Authors
Affiliations
Soon will be listed here.
Abstract

We evaluated the percentage of hospitalizations for acute respiratory tract infections in children < or =3 years of age attributable to human metapneumovirus (HMPV) and other respiratory viruses in a prospective study during winter and spring 2002. We used real-time polymerase chain assays and other conventional diagnostic methods to detect HMPV, human respiratory syncytial virus (HRSV), and influenza viruses in nasopharyngeal aspirates of children. HMPV was detected in 12 (6%) of the 208 children hospitalized for acute respiratory tract infections, HRSV in 118 (57%), and influenza A in 49 (24%). Bronchiolitis was diagnosed in 8 (68%) and pneumonitis in 2 (17%) of HMPV-infected children; of those with HRSV infection, bronchiolitiss was diagnosed in 99 (84%) and pneumonitis in 30 (25%). None of the HMPV-infected children was admitted to an intensive-care unit, whereas 15% of those with HRSV or influenza A infections were admitted. HMPV is an important cause of illness in young children with a similar, although less severe, clinical presentation to that of HRSV.

Citing Articles

A Re-emerging Respiratory Virus: Human Metapneumovirus (hMPV).

Mishra B, Mohapatra D, Tripathy M, Mamidi P, Mohapatra P Cureus. 2025; 17(2):e78354.

PMID: 40034641 PMC: 11875555. DOI: 10.7759/cureus.78354.


Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus.

Lee Y, Han J, Zhang Y, Ward G, Gomes K, Auclair S Nat Commun. 2024; 15(1):9939.

PMID: 39550381 PMC: 11569192. DOI: 10.1038/s41467-024-54287-x.


Interferon Epsilon-Mediated Antiviral Activity Against Human Metapneumovirus and Respiratory Syncytial Virus.

Martinez-Espinoza I, Babawale P, Miletello H, Cheemarla N, Guerrero-Plata A Vaccines (Basel). 2024; 12(10).

PMID: 39460364 PMC: 11511582. DOI: 10.3390/vaccines12101198.


Exploring Clinical Predictors of Severe Human Metapneumovirus Respiratory Tract Infections in Children: Insights from a Recent Outbreak.

Veronese A, Ursic T, Bizjak Vojinovic S, Rodman Berlot J Microorganisms. 2024; 12(4).

PMID: 38674586 PMC: 11052206. DOI: 10.3390/microorganisms12040641.


Respiratory Viral Coinfections: Insights into Epidemiology, Immune Response, Pathology, and Clinical Outcomes.

Babawale P, Guerrero-Plata A Pathogens. 2024; 13(4).

PMID: 38668271 PMC: 11053695. DOI: 10.3390/pathogens13040316.


References
1.
Jartti T, van den Hoogen B, Garofalo R, Osterhaus A, Ruuskanen O . Metapneumovirus and acute wheezing in children. Lancet. 2002; 360(9343):1393-4. PMC: 7119306. DOI: 10.1016/S0140-6736(02)11391-2. View

2.
Boivin G, Abed Y, Pelletier G, Ruel L, Moisan D, Cote S . Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J Infect Dis. 2002; 186(9):1330-4. DOI: 10.1086/344319. View

3.
Han L, Alexander J, Anderson L . Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis. 1998; 179(1):25-30. DOI: 10.1086/314567. View

4.
Simoes E . Respiratory syncytial virus infection. Lancet. 1999; 354(9181):847-52. DOI: 10.1016/S0140-6736(99)80040-3. View

5.
Mazzulli T, Peret T, McGeer A, Cann D, Macdonald K, Chua R . Molecular characterization of a nosocomial outbreak of human respiratory syncytial virus on an adult leukemia/lymphoma ward. J Infect Dis. 1999; 180(5):1686-9. DOI: 10.1086/315085. View